BTSG
BrightSpring Health Services, Inc.
-0.01 (-0.02%)58.95USD635K成交股數11.7B市值35.7本益比(近四季)0.8股價營收比+23.1%營收年增(近四季)2026-10-30下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 3.9B+23% | 3.6B+26% | 3.6B+36% | 3.3B+37% | 3.1B+38% | 2.9B+132% | 2.6B+15% | 2.4B+13% | 2.3B | 1.2B | 2.3B | 2.2B |
| 營業成本 | – | – | – | – | – | – | 2.5B | 2.3B | 2.2B | – | 1.9B | 1.8B |
| 毛利 | 493M+31% | 482M+43% | 413M+28% | 392M+26% | 375M+28% | 338M+358% | 323M-10% | 312M-16% | 292M | 73.9M | 358M | 372M |
| 毛利率 | 12.7% | 13.3% | 11.6% | 11.8% | 11.9% | 11.8% | 12.4% | 12.8% | 12.8% | 6.0% | 15.9% | 17.2% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 362M | 361M | 304M | 304M | 326M | 288M | 294M | 274M | 308M | 94.7M | 411M | 292M |
| 營業利益 | 130M+169% | 121M+139% | 108M+272% | 87.8M+127% | 48.6M-417% | 50.7M-344% | 29.1M-156% | 38.7M-51% | −15.3M | −20.8M | −52.3M | 79.6M |
| 營業利益率 | 3.4% | 3.4% | 3.0% | 2.6% | 1.5% | 1.8% | 1.1% | 1.6% | -0.7% | -1.7% | -2.3% | 3.7% |
| 稅後淨利 | 84.3M+199% | 149M+404% | 75.5M-1018% | 55.8M+180% | 28.2M-162% | 29.5M-552% | −8.2M-94% | 19.9M+399% | −45.8M | −6.5M | −131M | 4.0M |
| 淨利率 | 2.2% | 4.1% | 2.1% | 1.7% | 0.9% | 1.0% | -0.3% | 0.8% | -2.0% | -0.5% | -5.8% | 0.2% |
| 稀釋 EPS | 0.38+192% | 0.67+379% | 0.34-950% | 0.26+160% | 0.13-150% | 0.14-380% | -0.04-96% | 0.10+233% | -0.26 | -0.05 | -1.11 | 0.03 |
| 稀釋股數 | 220M | 221M | 220M | 218M | 216M | 215M | 198M | 209M | 176M | 118M | 118M | 126M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 550M | 889M | 88.4M | 140M | 70.1M | 52.3M | 36.0M | 25.0M | 58.0M | 12.4M | – | – |
| 應收帳款 | 1.1B | 1.1B | 990M | 1.0B | 973M | 975M | 1.0B | 985M | 991M | 767M | – | – |
| 存貨 | 575M | 560M | 815M | 639M | 625M | 534M | 478M | 374M | 374M | 399M | – | – |
| 總資產 | 6.0B | 6.2B | 6.4B | 6.0B | 5.9B | 5.8B | 5.8B | 5.6B | 5.7B | 5.5B | – | – |
| 有息負債 | 2.1B | 2.4B | 2.5B | 2.5B | 2.5B | 2.5B | 2.6B | 2.6B | 2.5B | 3.3B | – | – |
| 總負債 | 3.9B | 4.2B | 4.5B | 4.2B | 4.2B | 4.2B | 4.2B | 4.0B | 4.1B | 4.9B | – | – |
| 股東權益 | 2.0B | 2.0B | 1.9B | 1.8B | 1.7B | 1.7B | 1.6B | 1.6B | 1.6B | 585M | 632M | 749M |
| 負債比 | 65.6% | 68.0% | 70.6% | 69.9% | 70.6% | 71.1% | 72.0% | 71.3% | 72.2% | 88.9% | – | – |
| 淨現金(現金 − 有息負債) | −1.6B | −1.6B | −2.4B | −2.3B | −2.4B | −2.4B | −2.6B | −2.5B | −2.5B | −3.3B | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 123M+21% | – | – | – | 102M | – | – | −78.9M | – | – | – |
| 資本支出 | – | 21.5M | – | – | – | 17.6M | – | – | 21.8M | – | – | – |
| 自由現金流 | – | 101M+21% | – | – | – | 84.0M | – | – | −101M | – | – | – |
| 折舊攤銷 | – | 39.1M | – | – | – | 42.2M | 50.6M | 50.1M | 48.9M | 51.0M | 50.8M | 50.2M |
| 買回庫藏股 | – | 60.0M | – | – | – | – | – | – | 325K | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 2.8% | – | – | – | 2.9% | – | – | -4.4% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 12.9B
| Pharmacy Solutions | 11.4B | 88.7% | +30.7% |
|---|---|---|---|
| Provider Services | 1.5B | 11.3% | +11.1% |
產品／服務2025 年度 · 21.7B
| 產品 | 11.4B | 52.7% | +30.7% |
|---|---|---|---|
| Commercial Insurance | 3.3B | 15.2% | +30.7% |
| Medicare C | 2.4B | 11.1% | +44.9% |
| Medicaid | 1.5B | 6.9% | +28.2% |
| 服務 | 1.5B | 6.7% | +11.1% |
| Medicare A | 1.1B | 5.0% | +9.5% |
| Private And Other | 424M | 2.0% | +2.2% |
| Medicare B | 82.8M | 0.4% | -13.7% |
| Medicare D 小計 | 4.1B | 18.9% | +28.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 12.9B | +28.2% | 189M | 1.5% | 0.87 | 395M |
| FY2024 | 10.1B | +31.0% | 20.5M | 0.2% | -0.09 | −57.1M |
| FY2023 | 7.7B | +15.9% | −155M | -2.0% | -1.31 | 137M |
| FY2022 | 6.6B | – | −53.9M | -0.8% | -0.46 | −74.8M |